SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-011138
Filing Date
2016-01-06
Accepted
2016-01-06 16:12:02
Documents
2
Period of Report
2015-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2240
2 EX-24 DOCUMENT attachment1.htm EX-24 4289
  Complete submission text file 0000899243-16-011138.txt   8004
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Hashad Wael (Reporting) CIK: 0001663009 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 161326938